Buy a few shares under seven cents today. Becton Dickinson/LymPro news due out at any time.
Second "orphan indication" for the company's MANF drug is rumored to be in the field of diabetes. Novartis and Novo Nordisk are possible parties of interest.
Assuming the commercialization of LymPro on a worldwide basis occurs and there are five to ten orphan indications for MANF with accompanying "big pharma" development partnerships a billion dollars may be too low.
I think it is diabetes and I think Novartis and NovoNordisk are involved.
It has been rumored that Gerald was invited to Helsinki at the request of NovoNordisk. The company's area of focus is diabetes.
p.s. I'll try to keep you in line. I hope you're buying shares here.
Listen to the presentation. Several news things. Several definitive time frames. Many things in the works. ;)
Not true. Google "orphan indication diabetes"
Number of drugs to treat various forms of diabetes both type 1 and type 2 that have orphan indication.
Do better research.